Bloomberg via Facebook

“We have a broken antibiotic market, and this is a stunning example of how broken it is.”

Antibiotics Aren’t Profitable Enough for Big Pharma to Make More

Public health experts are calling for new incentives to reward companies for bringing drugs that are effective against resistant strains to market.


READ ALSO  The smiling ex-general who has become Indonesia’s ‘Mr Fixit’